| CSL01005 | 重组人血管内皮抑制素（UH－16） | | Other | Biological Products(1) | New Drug Application | 2001-01-22 | 烟台荣昌生物工程有限公司 | RemeGen Co Ltd | Certificate Issued | 2001-07-24 | view |
| CSL20020053 | 重组人血管内皮抑制素 | Recombinant Human Endostatin | Injection | Biological Products(1) | New Drug Application | 2002-07-15 | 广东肇庆星湖生物科技股份有限公司 | Star Lake Bioscience Co inc Zhaoqing Guangdong | Certificate Issued | 2003-05-16 | view |
| X0405545 | 重组人血管内皮抑制素 | Recombinant Human Endostatin | Injection | Biological Products | New Drug Application | 2004-09-30 | 烟台麦得津生物工程股份有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | Certificate Issued | 2005-09-22 | view |
| CXSB0600041 | 重组人血管内皮抑素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2006-06-16 | 江苏吴中实业股份有限公司 | JiangSu WuZhong Pharmaceutical Development Co Ltd | Certificate Issued | 2007-05-17 | view |
| CXSB0600125 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2006-12-14 | 山东先声麦得津生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | Certificate Issued | 2007-09-18 | view |
| CXSB0700080 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2007-08-27 | 山东先声麦得津生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | Certificate Issued | 2008-09-19 | view |
| CXSL0800037 | 聚乙二醇重组人血管内皮抑制素注射液 | | Injection | Biological Products(1) | New Drug Application | 2008-10-07 | 清华大学 | Tsinghua University | Certificate Issued | 2009-03-19 | view |
| CXSB1000006 | 聚乙二醇重组人血管内皮抑制素注射液 | | Injection | Biological Products | Supplementary Application | 2010-03-30 | 清华大学 | Tsinghua University | Certificate Issued | 2010-07-13 | view |
| CXSB1000001 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2010-04-12 | 山东先声麦得津生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | In Review | 2012-07-02 | view |
| CXSB1000018 | 重组人血管内皮抑素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2010-05-25 | 江苏吴中医药集团有限公司苏州中凯生物制药厂 | Jiangsu Wuzhong Pharmaceutical Group Co Ltd Suzhou Zhongkai Biopharmaceutical Factory | Certificate Issued | 2011-02-15 | view |
| CYSB1100375 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2011-07-27 | 山东先声麦得津生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | Certificate Issued | 2013-05-31 | view |
| CXSL1100045 | 注射用聚乙二醇化重组人血管内皮抑制素 | | Lyophilized | Biological Products(9) | New Drug Application | 2011-12-01 | 山东先声麦得津生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | Certificate Issued | 2014-07-31 | view |
| CXSS1800005 | 重组人血管内皮抑素注射液 | Recombinant Human Endostatin | Injection | Biological Products(1) | New Drug Application | 2018-03-09 | 江苏吴中医药集团有限公司苏州中凯生物制药厂 | Jiangsu Wuzhong Pharmaceutical Group Co Ltd Suzhou Zhongkai Biopharmaceutical Factory | Certificate Issued | 2019-07-17 | view |
| CYSB2000017 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2020-01-23 | 山东先声生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | In Review | 2020-01-22 | view |
| CXSL2100008 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products(2.2) | New Drug Application | 2021-01-09 | 山东先声生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | In Review | 2021-01-08 | view |
